Medtronic (MDT) Tops Q4 EPS by 3c, Offers FY19 Guidance

Go back to Medtronic (MDT) Tops Q4 EPS by 3c, Offers FY19 Guidance

Medtronic, Inc. (MDT) PT Raised to $95 at RBC Capital

May 25, 2018 6:39 AM EDT

RBC Capital raised its price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $92.00) while maintaining a Outperform rating.

Analyst Glenn Novarro commented, "All four segments participated in delivering a strong F4Q18, ahead of consensus and our estimate. The upper half of... More

Medtronic, Inc. (MDT) PT Raised to $97 at Needham & Company

May 24, 2018 5:12 PM EDT

Needham & Company raised its price target on Medtronic, Inc. (NYSE: MDT) to $97.00 (from $95.00) while maintaining a Buy rating.

Analyst Mike Matson commented, "F4Q18 revenue and EPS beat consensus. Management provided initial FY19 organic revenue guidance that was slightly below consensus and EPS guidance... More

Medtronic, Inc. (MDT) PT Raised to $87 at Stifel

May 24, 2018 2:13 PM EDT

Stifel raised its price target on Medtronic, Inc. (NYSE: MDT) to $87.00 (from $85.00) while maintaining a Hold rating.

... More

Medtronic, Inc. (MDT) PT Raised to $94 at Evercore ISI

May 24, 2018 1:49 PM EDT

Evercore ISI raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $90.00) while maintaining an Outperform rating following results.

What analyst Vijay Kumar liked:

Strong organic top-line sales growth of 6% driven by across the board business units and geographies strength, beating ST... More